Literature DB >> 32643094

Lower uric acid level may be associated with hemorrhagic transformation but not functional outcomes in patients with anterior circulation acute ischemic stroke undergoing endovascular thrombectomy.

Zhongyun Chen1, Hongbo Chen2, Yingbo Zhang3, Yanbo He4, Yingying Su5.   

Abstract

To determine the correlation of uric acid (UA) with hemorrhagic transformation (HT) and poor short-term functional outcomes in anterior circulation acute ischemic stroke (AIS) patients after endovascular thrombectomy (EVT). A retrospective analysis was conducted for anterior circulation AIS patients who underwent EVT at our hospital from 2015 to 2019. HT within 72 h was documented according to the European Cooperative Acute Stroke Study II Classification. Baseline demographic, clinical and laboratory data were compared between the HT and non-HT groups, and between patients with favorable and unfavorable outcomes on 90-day. A total of 247 AIS patients were enrolled, of which 92 (37.2%) and 85 (34.4%) experienced HT and had favorable functional outcomes at 3 months respectively. Patients with HT had significantly lower UA levels compared to those without HT (322.60 ± 94.49 vs. 350.25 ± 99.28 μmol /L, P = 0.032). In contrast, UA levels were similar in patients with good or poor outcomes (345.67 ± 103.55 vs. 336.95 ± 95.5 μmol /L, P = 0.509). Compared to the patients with UA levels in the first quartile, those in the fourth quartile were at a higher risk of HT in univariate logistic regression analysis (OR = 0.383, 95% CI = 0.173-0.848, P = 0.018). The association remained significant after multivariable adjustment for potential confounders. A lower UA level is an independent risk factor of HT post-EVT in anterior circulation AIS patients, but is not associated with the short-term functional outcomes.

Entities:  

Keywords:  Endovascular thrombectomy; Hemorrhagic transformation; Ischemic stroke; Prognosis; Uric acid

Mesh:

Substances:

Year:  2020        PMID: 32643094     DOI: 10.1007/s11011-020-00601-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  28 in total

Review 1.  Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke.

Authors:  Rakesh Khatri; Alexander M McKinney; Barbara Swenson; Vallabh Janardhan
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

2.  Uric acid improves glucose-driven oxidative stress in human ischemic stroke.

Authors:  Sergio Amaro; Laura Llull; Arturo Renú; Carlos Laredo; Belén Perez; Elisabet Vila; Ferrán Torres; Anna M Planas; Ángel Chamorro
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

3.  Hyperuricemia induces endothelial dysfunction.

Authors:  Uday M Khosla; Sergey Zharikov; Jennifer L Finch; Takahiko Nakagawa; Carlos Roncal; Wei Mu; Karina Krotova; Edward R Block; Sharma Prabhakar; Richard J Johnson
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

Review 4.  Serum uric acid and the risk of cardiovascular and renal disease.

Authors:  Claudio Borghi; Enrico Agabiti Rosei; Thomas Bardin; Jesse Dawson; Anna Dominiczak; Jan T Kielstein; Athanasios J Manolis; Fernando Perez-Ruiz; Giuseppe Mancia
Journal:  J Hypertens       Date:  2015-09       Impact factor: 4.844

5.  Uric acid levels are relevant in patients with stroke treated with thrombolysis.

Authors:  Sergio Amaro; Xabier Urra; Manuel Gómez-Choco; Víctor Obach; Alvaro Cervera; Martha Vargas; Ferran Torres; Jose Rios; Anna M Planas; Angel Chamorro
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

6.  Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.

Authors:  Sergio Amaro; Víctor Obach; Alvaro Cervera; Xabier Urra; Manuel Gómez-Choco; Anna M Planas; Angel Chamorro
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 7.  Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation.

Authors:  Ángel Chamorro; Ulrich Dirnagl; Xabier Urra; Anna M Planas
Journal:  Lancet Neurol       Date:  2016-05-11       Impact factor: 44.182

Review 8.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

9.  Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis.

Authors:  Jetan H Badhiwala; Farshad Nassiri; Waleed Alhazzani; Magdy H Selim; Forough Farrokhyar; Julian Spears; Abhaya V Kulkarni; Sheila Singh; Abdulrahman Alqahtani; Bram Rochwerg; Mohammad Alshahrani; Naresh K Murty; Adel Alhazzani; Blake Yarascavitch; Kesava Reddy; Osama O Zaidat; Saleh A Almenawer
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

10.  Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.

Authors:  Angel Chamorro; Sergio Amaro; Mar Castellanos; Tomás Segura; Juan Arenillas; Joan Martí-Fábregas; Jaime Gállego; Jurek Krupinski; Meritxell Gomis; David Cánovas; Xavier Carné; Ramón Deulofeu; Luis San Román; Laura Oleaga; Ferran Torres; Anna M Planas
Journal:  Lancet Neurol       Date:  2014-04-02       Impact factor: 44.182

View more
  2 in total

1.  Lower uric acid level may be associated with hemorrhagic transformation after intravenous thrombolysis.

Authors:  Yuxuan Tian; Qianqian Xie; Jiulin You; Shaonan Yang; Hongqin Zhao; Yuqiang Song
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

Review 2.  Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke.

Authors:  Guillaume Charbonnier; Louise Bonnet; Alessandra Biondi; Thierry Moulin
Journal:  Front Neurol       Date:  2021-02-09       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.